# Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

> **NCT03625219** · NA · COMPLETED · sponsor: **Innovaderm Research Inc.** · enrollment: 54 (actual)

## Conditions studied

- Delayed Type Hypersensitivity

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03625219
- **Lead sponsor:** Innovaderm Research Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-06-09
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625219, "Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03625219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*